Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.03
Delayed Data
As of Mar 04
 +0.25 / +3.69%
Today’s Change
3.10
Today|||52-Week Range
7.84
-7.01%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close6.78
Today’s open6.76
Day’s range-- - --
Volume1,124,345
Average volume (3 months)901,553
Market cap$471.6M
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+115.79%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratio140.6
Price/Sales37.83
Price/Book5.22

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...+0.34+2.58%
XNPTXenoport Inc0.000.00%
XOMAXOMA Corp-0.05-1.34%
VNDAVanda Pharmaceutical...+0.17+1.56%
Data as of 03/04/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account